SUPRIYA LIFESCIENCE
Quarterly Results Analysis [Mar2026]
SUPRIYA LIFESCIENCE Quarterly Results
| Standalone | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹277 Cr | ₹206 Cr | ₹200 Cr | ₹145 Cr | ₹184 Cr | ₹186 Cr | ₹166 Cr | ₹161 Cr |
| Expenses | ₹179 Cr | ₹134 Cr | ₹127 Cr | ₹93 Cr | ₹117 Cr | ₹120 Cr | ₹101 Cr | ₹98 Cr |
| Operating Income | ₹98 Cr | ₹72 Cr | ₹73 Cr | ₹52 Cr | ₹68 Cr | ₹66 Cr | ₹65 Cr | ₹63 Cr |
| Other Income | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| Profit Before Tax | ₹92 Cr | ₹67 Cr | ₹68 Cr | ₹47 Cr | ₹64 Cr | ₹63 Cr | ₹62 Cr | ₹60 Cr |
| Profit After Tax | ₹74 Cr | ₹50 Cr | ₹50 Cr | ₹35 Cr | ₹50 Cr | ₹47 Cr | ₹46 Cr | ₹45 Cr |
| EPS | ₹9.22 | ₹6.17 | ₹6.27 | ₹4.32 | ₹6.26 | ₹5.81 | ₹5.73 | ₹5.55 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUPRIYA LIFESCIENCE | -4.8% | 28.9% | 31% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.9% | -3.1% | 7.9% |
| DIVIS LABORATORIES | 2% | -2.1% | -0.9% |
| TORRENT PHARMACEUTICALS | -2.9% | -0.3% | 36.4% |
| CIPLA | -2.4% | -3.8% | -10.1% |
| DR REDDYS LABORATORIES | -0.5% | -5% | -6.9% |
| MANKIND PHARMA | 1.1% | -3.6% | -1% |
| LUPIN | 1.5% | 1.8% | 12.1% |
| ZYDUS LIFESCIENCES | -2.7% | 5.4% | 8.5% |
SUPRIYA LIFESCIENCE Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 33.95 % |
| Y-o-Y | 50.20 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹277 Cr | 33.95 | |
| Dec2025 | ₹206 Cr | 3.31 | |
| Sep2025 | ₹200 Cr | 37.75 | |
| Jun2025 | ₹145 Cr | -21.20 | |
| Mar2025 | ₹184 Cr | -0.83 | |
| Dec2024 | ₹186 Cr | 11.77 | |
| Sep2024 | ₹166 Cr | 3.41 | |
| Jun2024 | ₹161 Cr | - | |
SUPRIYA LIFESCIENCE Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 35.42 % |
| Y-o-Y | 44.44 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹98 Cr | 35.42 | |
| Dec2025 | ₹72 Cr | -0.78 | |
| Sep2025 | ₹73 Cr | 40.51 | |
| Jun2025 | ₹52 Cr | -23.50 | |
| Mar2025 | ₹68 Cr | 2.47 | |
| Dec2024 | ₹66 Cr | 1.91 | |
| Sep2024 | ₹65 Cr | 3.48 | |
| Jun2024 | ₹63 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 1.09 % |
| Y-o-Y | -3.84 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 35.3% | 1.09 | |
| Dec2025 | 34.92% | -3.93 | |
| Sep2025 | 36.35% | 1.99 | |
| Jun2025 | 35.64% | -2.91 | |
| Mar2025 | 36.71% | 3.32 | |
| Dec2024 | 35.53% | -8.80 | |
| Sep2024 | 38.96% | 0.05 | |
| Jun2024 | 38.94% | - | |
SUPRIYA LIFESCIENCE Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 49.43 % |
| Y-o-Y | 47.33 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹74 Cr | 49.43 | |
| Dec2025 | ₹50 Cr | -1.49 | |
| Sep2025 | ₹50 Cr | 44.95 | |
| Jun2025 | ₹35 Cr | -30.95 | |
| Mar2025 | ₹50 Cr | 7.70 | |
| Dec2024 | ₹47 Cr | 1.37 | |
| Sep2024 | ₹46 Cr | 3.37 | |
| Jun2024 | ₹45 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 11.55 % |
| Y-o-Y | -1.94 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 26.84 % | 11.55 | |
| Dec2025 | 24.06 % | -4.64 | |
| Sep2025 | 25.23 % | 5.21 | |
| Jun2025 | 23.98 % | -12.39 | |
| Mar2025 | 27.37 % | 8.61 | |
| Dec2024 | 25.2 % | -9.29 | |
| Sep2024 | 27.78 % | -0.04 | |
| Jun2024 | 27.79 % | - | |
SUPRIYA LIFESCIENCE Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 49.43 % |
| Y-o-Y | 47.28 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹9.22 | 49.43 | |
| Dec2025 | ₹6.17 | -1.59 | |
| Sep2025 | ₹6.27 | 45.14 | |
| Jun2025 | ₹4.32 | -30.99 | |
| Mar2025 | ₹6.26 | 7.75 | |
| Dec2024 | ₹5.81 | 1.40 | |
| Sep2024 | ₹5.73 | 3.24 | |
| Jun2024 | ₹5.55 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD